Back to results
US 2009/0023921 A1Published application
Methods for the preparation of hcv polymerase inhibitors
AssigneePfizer Inc.
InventorsChristopher Frederick Matthews, Robert William Scott, John Lloyd Tucker
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compounds useful in the preparation of compounds of the formula (I).
Claims12
A method of preparing a compound of formula (Ia):
- wherein:
- R1 is C1-C6 alkyl or C3-C6 cycloalkyl;
- R2a, R2b, and R2c are each independently selected from hydrogen, halogen, C1-C6 alkyl, C3-C6 cycloalkyl, —OR12a, —CF3, —CN, and —NR12aR12b;
- R4 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R5 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R6 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R7 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- each R9 and R10 is independently selected from hydrogen and C1-C6 alkyl, or R9 and
- R10, together with the carbon atom to which they are attached, form a C3-C6 cycloalkyl group;
- each R11 is independently selected from hydrogen, C1-C6 alkyl, halogen, —OR12a, —CN, —CF3, and —NR9R10;
- each R12a and R12b is independently selected from hydrogen and C1-C6 alkyl;
- and
- each n is independently chosen and is an integer from 0 to 5;
- said method comprising:
- a) treating a compound of formula (V), wherein R1 is defined above, with an anion of a compound of formula (X), wherein R13 is hydrogen, C1-C6 alkyl, —Si(C1-C6 alkyl)3, or —CH2(C6-C10 aryl), wherein said C6-C10 aryl group is optionally substituted with at least one substituent selected from halogen, C1-C6 alkyl, —OH, —OCH3, and —N(C1-C6 alkyl)2, to afford a compound of formula (IV);
- b) hydrolyzing the compound of formula (IV) to afford a compound of formula (IV) wherein R13 is hydrogen;
- c) treating the compound of formula (IV) with a combination of reagents to afford a compound of formula (III), wherein P1 is hydrogen or a suitable protecting group and R14 is C1-C6 alkyl or —CH2(C6-C10 aryl), wherein said C6-C10 aryl group is optionally substituted with at least one substituent selected from halogen, C1-C6 alkyl, —OH, —OCH3, and —N(C1-C6 alkyl)2;
- d) treating the compound of formula (III) with an acid or base to afford a compound of formula (II), and
- e) treating the compound of formula (II) with a compound of formula (Ixa), to afford the compound of formula (Ia)
16 more elements
A method of preparing a stereoisomerically enriched compound of formula (IV),
- wherein:
- R1 is C1-C6 alkyl or C3-C6 cycloalkyl;
- R4 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R5 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R6 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- R7 is selected from hydrogen, C1-C6 alkyl, —(CR9R10)nR11, —CF3, halogen, —OR12a, —CN, and —NR12aR12b;
- each R9 and R10 is independently selected from hydrogen and C1-C6 alkyl, or R9 and R10, together with the carbon atom to which they are attached, form of C3-C6 cycloalkyl group;
- each R11 is independently selected from hydrogen, C1-C6 alkyl, halogen, —OR12a, —CN, —CF3, and —NR12aR12b;
- each R12a and R12b is independently selected from hydrogen and C1-C6 alkyl;
- P1 is hydrogen or a suitable protecting group;
- and
- each n is independently chosen and is an integer from 0 to 5;
- said method comprising:
- a) treating a compound of formula (IV) with a chiral, non-racemic base to form a mixture of diastereomeric salts;
- b) separating said diastereomeric salts from each other;
- and
- c) converting said diastereomeric salts to a stereoisomerically enriched compound of formula (I).
14 more elements
A compound of formula (IV),
Dependencies are inferred from the claim text.